JP2019510025A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510025A5 JP2019510025A5 JP2018549444A JP2018549444A JP2019510025A5 JP 2019510025 A5 JP2019510025 A5 JP 2019510025A5 JP 2018549444 A JP2018549444 A JP 2018549444A JP 2018549444 A JP2018549444 A JP 2018549444A JP 2019510025 A5 JP2019510025 A5 JP 2019510025A5
- Authority
- JP
- Japan
- Prior art keywords
- acceptable salt
- compound
- pharmaceutically acceptable
- hydrogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662313334P | 2016-03-25 | 2016-03-25 | |
| US62/313,334 | 2016-03-25 | ||
| PCT/US2017/023126 WO2017165255A1 (en) | 2016-03-25 | 2017-03-20 | Pyrimidines and variants thereof, and uses therefor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019510025A JP2019510025A (ja) | 2019-04-11 |
| JP2019510025A5 true JP2019510025A5 (enExample) | 2020-04-09 |
| JP6902045B2 JP6902045B2 (ja) | 2021-07-14 |
Family
ID=59900805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549444A Active JP6902045B2 (ja) | 2016-03-25 | 2017-03-20 | ピリミジンおよびそのバリアント、ならびにそのための使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10662162B2 (enExample) |
| EP (1) | EP3433258B1 (enExample) |
| JP (1) | JP6902045B2 (enExample) |
| KR (1) | KR102377805B1 (enExample) |
| CN (1) | CN108779119B (enExample) |
| AU (1) | AU2017237929B2 (enExample) |
| CA (1) | CA3018180C (enExample) |
| MA (1) | MA44489A (enExample) |
| MX (1) | MX384368B (enExample) |
| RU (1) | RU2760733C2 (enExample) |
| WO (1) | WO2017165255A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10822311B2 (en) | 2016-03-14 | 2020-11-03 | Afferent Pharmaceuticals, Inc. | Pyrimidines and variants thereof, and uses therefor |
| WO2017165255A1 (en) * | 2016-03-25 | 2017-09-28 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
| WO2018116139A1 (en) | 2016-12-19 | 2018-06-28 | Novartis Ag | New picolinic acid derivatives and their use as intermediates |
| JP6934945B2 (ja) * | 2016-12-20 | 2021-09-15 | アファレント ファーマシューティカルズ インコーポレイテッド | Ｐ２ｘ３アンタゴニストの結晶塩および多形 |
| CA3076680A1 (en) * | 2017-11-01 | 2019-05-09 | Beijing Tide Pharmaceutical Co., Ltd. | P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof |
| CN107778255B (zh) * | 2017-11-16 | 2019-10-25 | 山东大学 | 一种二芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法和应用 |
| CN114007620B (zh) * | 2019-04-30 | 2024-08-06 | 北京泰德制药股份有限公司 | 二氨基嘧啶类化合物治疗子宫内膜异位相关的疼痛的方法 |
| MX2021013338A (es) * | 2019-04-30 | 2022-01-24 | Beijing Tide Pharmaceutical Co Ltd | Método para tratar la tos usando un compuesto de diaminopirimidina. |
| SG11202111907UA (en) * | 2019-04-30 | 2021-11-29 | Beijing Tide Pharmaceutical Co Ltd | Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof |
| EP3981765A4 (en) * | 2019-06-06 | 2023-05-31 | Beijing Tide Pharmaceutical Co., Ltd. | P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION CONTAINING IT AND THEIR USE |
| CN120058573A (zh) * | 2025-04-29 | 2025-05-30 | 潍坊学院 | 一种1-三溴甲基磺酰基萘及其衍生物的合成方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2953567A (en) * | 1956-11-23 | 1960-09-20 | Burroughs Wellcome Co | 5-phenylmercaptopyrimidines and method |
| CA2369945A1 (en) * | 1999-04-06 | 2000-10-12 | James L. Kelley | Neurotrophic thio substituted pyrimidines |
| CA2432799C (en) * | 2000-12-21 | 2008-08-19 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| PL1725540T3 (pl) * | 2004-03-05 | 2013-02-28 | Hoffmann La Roche | Diaminopirymidyny jako antagoniści p2x3 i p2x2/3 |
| JP4850911B2 (ja) * | 2005-09-01 | 2012-01-11 | エフ．ホフマン−ラ ロシュ アーゲー | Ｐ２ｘ３およびｐ２ｘ２／３モジュレーターとしてのジアミノピリミジン |
| JP4850912B2 (ja) * | 2005-09-01 | 2012-01-11 | エフ．ホフマン−ラ ロシュ アーゲー | Ｐ２ｘ３およびｐ３ｘ２／３モジュレーターとしてのジアミノピリミジン |
| KR101012926B1 (ko) * | 2005-09-01 | 2011-02-09 | 에프. 호프만-라 로슈 아게 | Ｐ2ｘ3 및 ｐ2ｘ2/3 조정자로서의 다이아미노피리미딘 |
| CN101300235B (zh) * | 2005-09-01 | 2011-12-07 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物 |
| SI2343281T1 (sl) * | 2006-10-04 | 2014-06-30 | F. Hoffmann-La Roche Ag | Postopek za sintezo fenoksi diaminopirimidinskih derivatov |
| WO2008104472A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | 2, 4 -diaminopyrimidine derivatives and their use as p2x antagonists or as prodrugs thereof |
| WO2008104474A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Diaminopyrimidines |
| CN101842359A (zh) * | 2007-10-31 | 2010-09-22 | 日产化学工业株式会社 | 哒嗪酮化合物和p2x7受体抑制剂 |
| GB2471713A (en) | 2009-07-08 | 2011-01-12 | Univ Greenwich | 1,2,4-triazine derivatives and their use as sodium channel blockers |
| TWI637949B (zh) * | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
| MX367657B (es) * | 2013-08-23 | 2019-08-30 | Afferent Pharmaceuticals Inc | Moduladores del receptor p2x3 y p2x2/3 de diaminopiridina para el tratamiento de la tos aguda, sub-aguda o crónica. |
| US10195198B2 (en) * | 2014-07-03 | 2019-02-05 | Afferent Pharmaceuticals, Inc. | Methods and compositions for treating diseases and conditions |
| US10822311B2 (en) * | 2016-03-14 | 2020-11-03 | Afferent Pharmaceuticals, Inc. | Pyrimidines and variants thereof, and uses therefor |
| WO2017165255A1 (en) | 2016-03-25 | 2017-09-28 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
-
2017
- 2017-03-20 WO PCT/US2017/023126 patent/WO2017165255A1/en not_active Ceased
- 2017-03-20 CN CN201780019534.0A patent/CN108779119B/zh active Active
- 2017-03-20 RU RU2018137032A patent/RU2760733C2/ru active
- 2017-03-20 MA MA044489A patent/MA44489A/fr unknown
- 2017-03-20 CA CA3018180A patent/CA3018180C/en active Active
- 2017-03-20 MX MX2018011622A patent/MX384368B/es unknown
- 2017-03-20 EP EP17770880.7A patent/EP3433258B1/en active Active
- 2017-03-20 AU AU2017237929A patent/AU2017237929B2/en active Active
- 2017-03-20 US US16/080,840 patent/US10662162B2/en active Active
- 2017-03-20 KR KR1020187029805A patent/KR102377805B1/ko active Active
- 2017-03-20 JP JP2018549444A patent/JP6902045B2/ja active Active
-
2020
- 2020-04-13 US US16/846,452 patent/US11230532B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019510025A5 (enExample) | ||
| MX2018009840A (es) | Sulfonilureas y compuestos relacionados y sus usos. | |
| JP2017509586A5 (enExample) | ||
| RU2018137032A (ru) | Пиримидины и их варианты, и их применение | |
| JP2015517981A5 (enExample) | ||
| JP2009532486A5 (enExample) | ||
| JOP20200194A1 (ar) | صور بلورية جديدة | |
| JP2006515858A5 (enExample) | ||
| JP2018516904A5 (enExample) | ||
| JP2017533968A5 (enExample) | ||
| JP2011219498A5 (enExample) | ||
| JP2012140432A5 (enExample) | ||
| HRP20211041T1 (hr) | Anthelmintski depsipeptidni spojevi | |
| JP2016534134A5 (enExample) | ||
| JP2013505903A5 (enExample) | ||
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| JP2016515131A5 (enExample) | ||
| JP2016505637A5 (enExample) | ||
| JP2016530213A5 (enExample) | ||
| JP2019501130A5 (enExample) | ||
| JP2011526913A5 (ja) | キナゾリン化合物及び同化合物を含む治療薬 | |
| JP2018527301A5 (ja) | アジリジン含有ｄｎａアルキル化剤 | |
| JP2020521772A5 (enExample) | ||
| JP2016516028A5 (enExample) | ||
| JP2015522606A5 (enExample) |